Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,152
Closed -$210K 152
2023
Q1
$210K Buy
5,152
+174
+3% +$7.51K 0.02% 138
2022
Q4
$255K Buy
4,978
+187
+4% +$8.96K 0.02% 124
2022
Q3
$210K Hold
4,791
0.02% 130
2022
Q2
$251K Sell
4,791
-100
-2% -$5.1K 0.02% 127
2022
Q1
$253K Sell
4,891
-386
-7% -$20K 0.02% 139
2021
Q4
$277K Buy
+5,277
New +$261K 0.02% 133
2021
Q2
Sell
-9,237
Closed -$333K 177
2021
Q1
$333K Buy
9,237
+1,424
+18% +$50.6K 0.03% 120
2020
Q4
$292K Sell
7,813
-506
-6% -$18.6K 0.03% 118
2020
Q3
$287K Sell
8,319
-117
-1% -$4.1K 0.04% 111
2020
Q2
$307K Sell
8,436
-1,424
-14% -$48.4K 0.04% 121
2020
Q1
$348K Sell
9,860
-2,207
-18% -$75.2K 0.06% 112
2019
Q4
$432K Sell
12,067
-651
-5% -$23.2K 0.09% 115
2019
Q3
$442K Buy
12,718
+4,888
+62% +$178K 0.11% 107
2019
Q2
$270K Sell
7,830
-790
-9% -$31.4K 0.08% 125
2019
Q1
$347K Sell
8,620
-777
-8% -$31.1K 0.11% 111
2018
Q4
$389K Buy
+9,397
New +$390K 0.19% 84

Other funds holding PFE

Full Sail Capital's PFE Position: Q2 2023 in Review

Full Sail Capital sold out of Pfizer (PFE) in Q2 2023, closing a stake of 5,152 shares — an estimated $210K sold.

Full Sail Capital first reported a position in PFE in Q4 2018 and held it in 16 quarters. The position peaked at $442K in Q3 2019. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

  • Full Sail Capital reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
  • Full Sail Capital sold 5,152 Pfizer shares in Q2 2023, an estimated $210K.
  • Full Sail Capital first reported a position in Pfizer in Q4 2018 and held it in 16 quarters.
  • Full Sail Capital's Pfizer position peaked at $442K in Q3 2019.
  • 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on Full Sail Capital's 13F filing for Q2 2023, filed 14 Aug 2023.